Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support.
Gulbrandsen N, Wisløff F, Brinch L, Carlson K, Dahl IM, Gimsing P, Hippe E, Hjorth M, Knudsen LM, Lamvik J, Lenhoff S, Løfvenberg E, Nesthus I, Nielsen JL, Turesson I, Westin J; Nordic Myeloma Study Group.
Gulbrandsen N, et al. Among authors: hippe e.
Med Oncol. 2001;18(1):65-77. doi: 10.1385/MO:18:1:65.
Med Oncol. 2001.
PMID: 11778972
Clinical Trial.